Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen.

Publication ,  Journal Article
Hess, PR; Boczkowski, D; Nair, SK; Snyder, D; Gilboa, E
Published in: Cancer Immunol Immunother
June 2006

Immunization of mice with dendritic cells transfected ex vivo with tumor-associated antigen (TAA)-encoding mRNA primes cytotoxic T lymphocytes (CTL) that mediate tumor rejection. Here we investigated whether direct injection of TAA mRNA, encapsulated in cationic liposomes, could function similarly as cancer immunotherapy. Intradermal and intravenous injection of ovalbumin (OVA) mRNA generated specific CTL activity and inhibited the growth of OVA-expressing tumors. Vaccination studies with DNA have demonstrated that co-administration of antigen (Ag)- and cytokine-encoding plasmids potentiate the T cell response; in analogous fashion, the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA enhanced OVA-specific cytotoxicity. The ability of this GM-CSF-augmented mRNA vaccine to treat an established spontaneous tumor was evaluated in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mouse, using the SV40 large T Ag (TAg) as a model tumor/self Ag. Repeated vaccination elicited vigorous TAg-specific CTL activity in nontransgenic mice, but tumor-bearing TRAMP mice remained tolerant. Adoptive transfer of naïve splenocytes into TRAMP mice prior to the first vaccination restored TAg reactivity, and slowed tumor progression. The data from this study suggests that vaccination with TAA mRNA is a simple and effective means of priming antitumor CTL, and that immunogenicity of the vaccine can be augmented by co-delivery of GM-CSF mRNA. Nonetheless, limitations of such vaccines in overcoming tolerance to tumor/self Ag may mandate prior or simultaneous reconstitution of the autoreactive T cell repertoire for this form of immunization to be effective.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Immunol Immunother

DOI

ISSN

0340-7004

Publication Date

June 2006

Volume

55

Issue

6

Start / End Page

672 / 683

Location

Germany

Related Subject Headings

  • Transfection
  • T-Lymphocytes, Cytotoxic
  • RNA, Messenger
  • Prostatic Neoplasms
  • Polymerase Chain Reaction
  • Mice, Transgenic
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Liposomes
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hess, P. R., Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (2006). Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Immunol Immunother, 55(6), 672–683. https://doi.org/10.1007/s00262-005-0064-z
Hess, Paul R., David Boczkowski, Smita K. Nair, David Snyder, and Eli Gilboa. “Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen.Cancer Immunol Immunother 55, no. 6 (June 2006): 672–83. https://doi.org/10.1007/s00262-005-0064-z.
Journal cover image

Published In

Cancer Immunol Immunother

DOI

ISSN

0340-7004

Publication Date

June 2006

Volume

55

Issue

6

Start / End Page

672 / 683

Location

Germany

Related Subject Headings

  • Transfection
  • T-Lymphocytes, Cytotoxic
  • RNA, Messenger
  • Prostatic Neoplasms
  • Polymerase Chain Reaction
  • Mice, Transgenic
  • Mice, Inbred C57BL
  • Mice
  • Male
  • Liposomes